COMMUNIQUÉS West-GlobeNewswire

Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 10, 2018
06/11/2018
Event will provide a review of new CPI-444 and CPI-006 data presented at SITC & ESMO BURLINGAME, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage [...]
OpGen Announces Date of Third Quarter 2018 Financial Results Conference Call
05/11/2018
GAITHERSBURG, Md., Nov. 05, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced that the Company will report financial results for the three and nine months ended September 30, 2018 after the close of [...]
Kane Biotech Appoints Dr. Gordon Guay as Chief Scientific Officer
05/11/2018
WINNIPEG, Manitoba, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), today announced the appointment of Gordon Guay, Ph.D., a member of Kane’s [...]
Syneos Health to Present at the Jefferies 2018 London Healthcare Conference
05/11/2018
RALEIGH, N.C., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract [...]
The Ensign Group to Present at the 2018 Stephens Fall Investment Conference on Tuesday, November 6, 2018
05/11/2018
MISSION VIEJO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
ReWalk Robotics to Report Third Quarter 2018 Financial Results on November 8, 2018
05/11/2018
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 05, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2018 [...]
Clearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to Follow
05/11/2018
ALPHARETTA, Ga., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
INSYS Therapeutics Reports Third Quarter 2018 Results
05/11/2018
Company’s Position as a Leader and Strategic Partner in Pharmaceutical Cannabinoids Strengthens with Involvement in Seven CBD Clinical Trials PHOENIX, Nov. 05, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: [...]
Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference
05/11/2018
DUBLIN, Ireland and TREVOSE, Pa., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
INSYS Therapeutics to Assess Strategic Alternatives for Opioid-Related Assets
05/11/2018
Company Reiterates Focus on Pharmaceutical Cannabinoids and Spray Technology PHOENIX, Nov. 05, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and [...]
Otonomy Reports Third Quarter 2018 Financial Results and Provides Corporate Update
05/11/2018
Conference call and webcast today at 4:30 p.m. EST Conference call will include review of OTO-413 program selected as "Hot Topic" at Society for Neuroscience Annual Meeting SAN DIEGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- [...]
EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize Durasert™ Three-Year Treatment for Posterior Segment Uveitis in the Greater China Region
05/11/2018
WATERTOWN, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, and [...]
Alder BioPharmaceuticals® Reports Third Quarter 2018 Financial and Operating Results
05/11/2018
- Biologics License Application (BLA) submission on track for Q1 2019 - - Robust manufacturing package for BLA submission to include positive results from pharmacokinetic comparability study - - Conference call today at [...]
Iterum Therapeutics plc to Participate in Investor Conferences in November and December
05/11/2018
DUBLIN, Ireland and CHICAGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today [...]
Kura Oncology Reports Third Quarter 2018 Financial Results and Provides Corporate Update
05/11/2018
– Registration-directed trial of tipifarnib in HRAS mutant HNSCC now underway – – Encouraging preliminary clinical activity observed in HRAS mutant SCC cohort – – Preliminary data from AITL and CXCL12+ cohorts in Phase [...]
Rubius Therapeutics to Announce Third Quarter 2018 Financial Results
05/11/2018
CAMBRIDGE, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, plans to report third quarter 2018 [...]
Akcea Reports Financial Results and Highlights for Third Quarter 2018
05/11/2018
TEGSEDI TM (inotersen) Approved in United States, European Union & Canada $320 million to fund the company through key milestones Conference Call Webcast Monday, November 5, 4:30 p.m. ET at www.akceatx.com BOSTON, [...]
Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update
05/11/2018
NOVATO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Sunesis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Highlights
05/11/2018
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the quarter [...]

Pages